During the last session, Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s traded shares were 1.97 million, with the beta value of the company hitting 0.38. At the end of the trading day, the stock’s price was $1.08, reflecting an intraday gain of 2.86% or $0.03. The 52-week high for the SLRX share is $7.20, that puts it down -566.67 from that peak though still a striking 58.33% gain since the share price plummeted to a 52-week low of $0.45. The company’s market capitalization is $2.30M, and the average intraday trading volume over the past 10 days was 6.76 million shares, and the average trade volume was 1.23 million shares over the past three months.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information

Salarius Pharmaceuticals Inc (SLRX) registered a 2.86% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.86% in intraday trading to $1.08, hitting a weekly high. The stock’s 5-day price performance is 45.99%, and it has moved by 32.52% in 30 days. Based on these gigs, the overall price performance for the year is -68.06%. The short interest in Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is 47988.0 shares and it means that shorts have 1.67 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 57.63%.

SLRX Dividends

Salarius Pharmaceuticals Inc is due to release its next quarterly earnings on 2025-Mar-21. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders

Salarius Pharmaceuticals Inc insiders own 1.70% of total outstanding shares while institutional holders control 6.57%, with the float percentage being 6.69%.